Shiho Kuji

Shiho Kuji

Auto-generated profile, based on publicly available information

Shiho Kuji

Department of Obstetrics and Gynecology, St. Marianna Medical University School of Medicine, Kawasaki, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
SKShiho Kuji
Shiho Kuji
RWReiko Watanabe
Reiko Watanabe
YSYuichi Sato
Yuichi Sato
TITakashi Iwata
Takashi Iwata
YHYasuyuki Hirashima
Yasuyuki Hirashima
TKToru Kameya
Toru Kameya

1 June 2013 in Gynecologic Oncology
Verified
Journal Article
Closed access
SKShiho Kuji
Shiho Kuji
YHYasuyuki Hirashima
Yasuyuki Hirashima
HNHiroki Nakayama
Hiroki Nakayama
Shin NishioShin Nishio
Shin Nishio
TOTakeo Otsuki
Takeo Otsuki
TYTakashi Yamada
Takashi Yamada

1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
HMHarunobu Matsumoto
Harunobu Matsumoto
MSMototsugu Shimokawa
Mototsugu Shimokawa
KNKaei Nasu
Kaei Nasu
ASAyumi Shikama
Ayumi Shikama
TSTakaya Shiozaki
Takaya Shiozaki
NTNorihiro Teramoto
Norihiro Teramoto
We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its clinicopathologic features, treatment, prognosis and prognostic factors to collate findings to establish future individualized treatment regimens. To our knowledge, this is the largest case study and the first study to statistically analyze the prognosis of this disease. At medical institutions participating in the Kansai Clinical Oncology Group/Intergroup, cases diagnosed at a central pathologic review as neuroendocrine carcinoma of the endometrium between 1995 and 2014 were enrolled. We retrospectively analyzed the clinicopathologic features, treatment, prognosis and prognostic factors of this disease. A total of 65 cases were registered from 18 medical institutions in Japan. Of these, 42 (64.6%) cases were diagnosed as neuroendocrine carcinoma of the endometrium based on the central pathological review and thus included in the study. Advanced International Federation of Gynecology and Obstetrics stages (stage III and IV) and pure type small cell neuroendocrine carcinoma cases had a significantly worse prognosis. Upon multivariate analysis, only histologic subtypes and surgery were significant prognostic factors. Pure type cases had a significantly worse prognosis compared to mixed type cases and complete surgery cases had a significantly better prognosis compared to cases with no or incomplete surgery. Our findings suggest that complete surgery improves the prognosis of neuroendocrine carcinoma of the endometrium. Even among cases with advanced disease stages, if complete surgery is expected to be achieved, clinicians should consider curative surgery to improve the prognosis of neuroendocrine carcinoma of the endometrium.

1 January 2014 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SKShiho Kuji
Shiho Kuji
YHYasuyuki Hirashima
Yasuyuki Hirashima
SKSatomi Komeda
Satomi Komeda
ATAki Tanaka
Aki Tanaka
MAMasakazu Abe
Masakazu Abe
MTMunetaka Takekuma
Munetaka Takekuma
Kuji S, et al. J Gynecol Oncol. 2014 Apr;25(2):90-96. http://dx.doi.org/10.3802/jgo.2014.25.2.90

1 January 2023 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SKShiho Kuji
Shiho Kuji
AEAkira Endo
Akira Endo
MKManabu Kubota
Manabu Kubota
AUAtsushi Uekawa
Atsushi Uekawa
FKFumi Kawakami
Fumi Kawakami
NSNao Suzuki
Nao Suzuki
Kuji S, et al. J Gynecol Oncol. 2022 Oct;34(1):e1. https://doi.org/10.3802/jgo.2023.34.e1